[Clinical outcome of the hyperacute form of acute disseminated encephalomyelitis]

R Reig Sáenz1, C Zazo Santidrián, P Martín Medina

  • 1Unidad de Cuidados Intensivos Pediátricos, Servicio de Medicina Intensiva, Hospital General Universitario de Alicante, Alicante, España. reig_rob@gva.es

Abstract

Insights

A severe, rapid form of acute disseminated encephalomyelitis (ADEM) presents with high mortality. Early treatment with methylprednisolone and immunoglobulins may improve outcomes, but MRI lesions persist short-term.

Area of Science:

  • Neurology
  • Pediatric Intensive Care
  • Neuroimmunology

Context:

  • Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system.
  • The hyperacute form of ADEM presents a diagnostic and therapeutic challenge, often with severe neurological deficits.

Purpose:

  • To describe the clinical characteristics, management, and outcomes of five pediatric patients with hyperacute ADEM admitted to the Paediatric Intensive Care Unit (PICU).
  • To evaluate the short-term and long-term outcomes in a cohort of children with severe ADEM.

Summary:

  • Five male patients with a mean age of 5.2 years presented with coma and mechanical ventilation requirements within 24 hours of initial neurological symptoms.
  • Brain MRI revealed white matter and basal ganglia lesions, with spinal cord involvement in three cases. Treatment included high-dose methylprednisolone, immunoglobulins, and plasmapheresis in one patient.
  • Two patients died, one had severe sequelae, but survivors showed significant neurological recovery at nine months, despite persistent MRI lesions.

Impact:

  • Highlights the existence of a hyperacute ADEM variant with significant mortality and morbidity.
  • Suggests that aggressive immunosuppressive therapy may lead to clinical recovery despite persistent radiological evidence of disease activity.
  • Emphasizes the need for prompt recognition and intensive management of hyperacute ADEM in pediatric critical care settings.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...